MWNA
KLRS

Marshall Wace North America’s Kalaris Therapeutics KLRS Stock Holding History

Marshall Wace North America’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$8.14M Hold
14,116
– – 0.03% 397
2021
Q2 		$6.41M Sell
14,116
-146
-1% -$75.4K 0.03% 481
2021
Q1 		$7.68M Buy
14,262
+146
+1% +$123K 0.03% 456
2020
Q4 		$12.5M Sell
14,116
-11,140
-44% -$8.57M 0.06% 335
2020
Q3 		$16M Buy
+25,256
New +$17.2M 0.1% 215

Other funds holding KLRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return